Phase III studies support pediatric label extension of JE vaccine for children traveling to endemic areas.

New Thermotrek™ range of products designed for moving temperature sensitive medicines.

HiPPR detergent removal resin for the efficient cleanup of protein and peptide solutions.

Furnaces used to develop and manufacture innovative orthobiologic graft products.

New research published in BioMed Central’s open access journal BMC Gastroenterology shows that luteolin is able to inhibit the activity of cell signaling pathways (IGF and PI3K) important for the growth of cancer in colon cancer cells.

The companies have started a joint global marketing and sales effort and collaborative R&D activities in the area of downstream purification as part of the manufacturing of vaccine, DNA and antibody based medicines.

Software offers unrivalled performance in speed, image quality and analysis, allowing acquisition and analysis of more than 10 million cells per hour.

PEIpro™ further expands an already rich catalogue of innovative reagents.

The Center for Human Genetics and Laboratory Medicine and IMGM Laboratories reported using the benchtop system to sequence clinically relevant exons and identify genomic variations in solid tumors treated with an antibody-based medicine.

As part of this acquisition, Professor Arash Sahraie has joined NovaVision as its Chief Scientific Officer on a part-time secondment basis from the University of Aberdeen for a minimum of five years.